Table 2.
Risk factor analysis for in-hospital death in high risk patients (EA ≥ 0.54 at T0) and in low risk patients (EA < 0.54 at T0).
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
OR (95% CI) | p value | OR (95% CI) | p value | |
In high risk patients (EA at T0 ≥ 0.54) | ||||
PMX-HP treatment | 0.53 (0.13–2.20) | 0.18 | 0.04 (0.01–0.71) | 0.03 |
Age (years) | 1.01 (0.94–1.08) | 0.76 | ||
APACHE II at admission | 1.01 (0.93–1.09) | 0.83 | ||
SOFA score at T0 | 1.24 (1.03–1.49) | 0.02 | 1.56 (1.13–2.16) | 0.007 |
Duration of surgery (min) | 1.01 (0.99–1.01) | 0.47 | ||
In low risk patients (EA at T0 < 0.54) | ||||
PMX-HP treatment | 4.00 (0.45–35.79) | 0.22 | ||
Age (years) | 1.03 (0.94–1.13) | 0.54 | ||
APACHE II at admission | 1.16 (0.99–1.36) | 0.055 | ||
SOFA score at T0 | 1.28 (1.00–1.64) | 0.047 | 1.28 (1.00–1.64) | 0.047 |
Duration of surgery (min) | 0.98 (0.96–1.00) | 0.078 |
APACHE Acute physiology and Chronic Health Evaluation, CI confidence interval, EA Endotoxin activity, OR Odd ratio, PMX-HP Polymyxin B-hemoperfusion, SOFA Sequential Organ Failure Assessment.
Significant values are in [italics].